Clinical trial
Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing…
NCT00477607 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00477607 |
|---|---|
| Title | Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin |
| Official title | Prevention of Cisplatin Ototoxicity With the Antioxidant Alpha-Lipoic Acid |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | Oregon Health and Science University |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Ototoxicity, Unspecified Adult Solid Tumor |
| Intervention type | Behavioral, Biological, Drug |
| Interventions | alpha-lipoic acid, Audiology, laboratory biomarker analysis, Placebo |
| Enrollment | 39 |
| Start date | Oct 1, 2007 |
| Primary completion | Mar 1, 2011 |
| Completion | Jun 1, 2011 |
| First posted | May 24, 2007 |
| Last update posted | Mar 7, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: